The Future of Dr. Consumers: How Healthcare Should Adapt to the Integration of Digital Therapeutics
SUMMARY
As patients become more empowered in their own health journeys, they’re becoming more fluent in wearables and digital health apps. At the Health Innovation Summit 2022, Hamid Ghanadan talks with Erin Coward of JPMorgan Chase & Co about how practitioners and experts in digital therapeutics (DTx) can adapt to this new generation of patients.
Today’s consumers are becoming more empowered in their own health journeys, and in turn, becoming more fluent in digital therapeutics and health tech that allows them to access their own data like never before. These “Dr. Consumers” have more access to data about themselves than ever before, often taking on the role of being their own healthcare providers. This trend, driven both by the pandemic and the burgeoning market for health tech offerings like wearables and digital therapeutics, is deeply integrated and normalized into the future of healthcare. So how can practitioners in healthcare adapt to this new generation of patients?
On stage at the Health Innovation Summit, LINUS founder Hamid Ghanadan spoke with Erin Coward (Regional Executive, Southern Region — Healthcare Services & Life Sciences at JPMorgan Chase & Co) about how data driven insights can positively change the future of healthcare.
“It’s the responsibility of the DTx innovators to ensure we first understand the drivers and needs of the communities we serve — not just the overt, functional need but the emotional need,” says Hamid. “So the bigger question may not be whether society is ready for digital therapeutics, but whether digital therapeutics technology is ready for society?”
Reports referenced:
Home is the Center of Health
Gen Z + The Future of Health